We have the pleasure to invite you to the 2nd national CAR-T symposium in Belgium: The journey so far.
We have the pleasure to invite you to the 2nd national CAR-T symposium in Belgium: The journey so far.
Scientific program: 19h-21h05
19h00
Introduction and opening remarks
19h10
CAR-T Cell Therapy. The Evidence in Belgium so Far
Dr. Sarah Bailly (Cliniques Universitaires Saint-Luc) and Dr. Sophie Servais (CHU Liège)
19h25
Practical Considerations for CAR-T Cell Therapy
Prof. Peter Vandenberghe (UZ Leuven) & Prof.Tessa Kerre (UZ Gent)
19h45
Treatment of r/r ALL: New Insights
Prof. Barbara De Moerloose (UZ Gent)
19h55
International Speaker: Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell therapy: long term management of patients post CAR-T
Prof. Elise Chong (University of Pennsylvania)
20h15
Panel Discussion and Live Q&A: From Primary Hematologist to CAR-T Center and Back
21h00
Closing Remarks
Faculties:
This symposium is the result of a collaboration between physicians of 4 academic hematology departments and an Academic Pediatric hematology/Oncology department with the support of Novartis.
Guest lecture:
Elise Chong is Assistant Professor of Medicine and member of the faculty of the Division of Hematology/Oncology at the Hospital of the University of Pennsylvania.
As associate Director of the Abramson Cancer Center’s Lymphoma Clinical Trials Research Unit, she is conducting research in the area of lymphoma, immunotherapy, and cellular therapy with an emphasis on translational clinical trials.
